http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665356-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4c4ce9456a44137f79ae4c70df89d75
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
filingDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183dce85a72c4dcbddfd2443fd331186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d09835aaa3181766167b889a822d36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c6cfea33b5413e6ce13376871c979a
publicationDate 1997-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5665356-A
titleOfInvention Human anti-Rh (D) monoclonal antibodies
abstract The present invention provides human monoclonal antibodies having the following essential characteristics: (a) binding to Rh(D) antigen, but not C, c, E or e antigens of the Rh blood group system; (b) being IgG1 proteins; (c) having kappa light chains; (d) being Glm(3) or Glm(1,17) allotype; (e) binding to Du cells by an indirect antiglobulin test; (f) binding to DIV, DV and DVII variant antigens; and (g) not binding to DVI or DB variant antigens, which may be employed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. Such a monoclonal antibody is exemplified by the monoclonal antibodies of cell lines ECACC 87091605 and 87091604 deposited at the European Collection of Animal Cell Cultures, Public Health Laboratory Service Center for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, SP4, OJG, England on Sep. 16, 1987.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002199218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010148501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003092014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2045602-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093004-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005152853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7553629-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7597895-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2311490-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7556807-B2
priorityDate 1987-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0251440-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8502413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8902443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2145113-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128548416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028

Total number of triples: 70.